{"id":"https://openalex.org/W2322345488","doi":"https://doi.org/10.1038/sj.onc.1205449","title":"Enhanced tumor killing by Apo2L/TRAIL and CPT-11 co-treatment is associated with p21 cleavage and differential regulation of Apo2L/TRAIL ligand and its receptors","display_name":"Enhanced tumor killing by Apo2L/TRAIL and CPT-11 co-treatment is associated with p21 cleavage and differential regulation of Apo2L/TRAIL ligand and its receptors","publication_year":2002,"publication_date":"2002-05-16","ids":{"openalex":"https://openalex.org/W2322345488","doi":"https://doi.org/10.1038/sj.onc.1205449","mag":"2322345488","pmid":"https://pubmed.ncbi.nlm.nih.gov/12032863"},"language":"en","primary_location":{"id":"doi:10.1038/sj.onc.1205449","doi":"https://doi.org/10.1038/sj.onc.1205449","is_oa":false,"landing_page_url":"https://doi.org/10.1038/sj.onc.1205449","pdf_url":null,"source":{"id":"https://openalex.org/S128439998","display_name":"Oncogene","issn_l":"0950-9232","issn":["0950-9232","1476-5594"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncogene","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5080743064","display_name":"Hong Xiang","orcid":"https://orcid.org/0000-0001-6753-4283","observed_orcids":["https://orcid.org/0000-0001-6753-4283"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hong Xiang","raw_affiliation_strings":["Department of Clinical and Experimental Pharmacology; Genentech, Inc., 1 DNA Way, South San Francisco, California, CA 94080, USA","Department of Clinical and Experimental Pharmacology, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical and Experimental Pharmacology; Genentech, Inc., 1 DNA Way, South San Francisco, California, CA 94080, USA","institution_ids":["https://openalex.org/I183934855"]},{"raw_affiliation_string":"Department of Clinical and Experimental Pharmacology, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, California, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050940843","display_name":"Judith Ann Fox","orcid":"https://orcid.org/0000-0002-6084-7380","observed_orcids":["https://orcid.org/0000-0002-6084-7380"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Judith A Fox","raw_affiliation_strings":["Department of Clinical and Experimental Pharmacology, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical and Experimental Pharmacology, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, California, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009606169","display_name":"Kl\u00e1ra T\u00f3tp\u00e1l","orcid":"https://orcid.org/0000-0001-6629-6623","observed_orcids":["https://orcid.org/0000-0001-6629-6623"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Klara Totpal","raw_affiliation_strings":["Department of Molecular Oncology, Genentech, Inc., 1 DNA Way, South San Francisco, 94080, California, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular Oncology, Genentech, Inc., 1 DNA Way, South San Francisco, 94080, California, CA, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103496917","display_name":"Mina Aikawa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mina Aikawa","raw_affiliation_strings":["Department of Clinical and Experimental Pharmacology, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical and Experimental Pharmacology, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, California, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038315593","display_name":"Kelly DuPree","orcid":"https://orcid.org/0009-0006-2747-3918","observed_orcids":["https://orcid.org/0009-0006-2747-3918"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kelly Dupree","raw_affiliation_strings":["Department of BioAnalytical R&D, Genentech, Inc., 1 DNA Way, South San Francisco, 94080, California, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of BioAnalytical R&D, Genentech, Inc., 1 DNA Way, South San Francisco, 94080, California, CA, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069498671","display_name":"Dominick V. Sinicropi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dominick Sinicropi","raw_affiliation_strings":["Department of BioAnalytical R&D, Genentech, Inc., 1 DNA Way, South San Francisco, 94080, California, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of BioAnalytical R&D, Genentech, Inc., 1 DNA Way, South San Francisco, 94080, California, CA, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039200074","display_name":"John R. Lowe","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Lowe","raw_affiliation_strings":["Department of BioAnalytical R&D, Genentech, Inc., 1 DNA Way, South San Francisco, 94080, California, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of BioAnalytical R&D, Genentech, Inc., 1 DNA Way, South San Francisco, 94080, California, CA, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5077111567","display_name":"Enrique Escand\u00f3n","orcid":"https://orcid.org/0000-0002-2297-969X","observed_orcids":["https://orcid.org/0000-0002-2297-969X"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Enrique Escand\u00f3n","raw_affiliation_strings":["Department of Clinical and Experimental Pharmacology, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical and Experimental Pharmacology, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, California, USA","institution_ids":["https://openalex.org/I183934855"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I183934855"],"apc_list":{"value":5990,"currency":"USD","value_usd":5990},"apc_paid":null,"fwci":1.9121,"has_fulltext":false,"cited_by_count":50,"citation_normalized_percentile":{"value":0.85826592,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":95},"biblio":{"volume":"21","issue":"22","first_page":"3611","last_page":"3619"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13026","display_name":"Natural Compounds in Disease Treatment","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2707","display_name":"Complementary and alternative medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/apo2l-trail","display_name":"Apo2L/TRAIL","score":0.996999979019165},{"id":"https://openalex.org/keywords/irinotecan","display_name":"irinotecan","score":0.9580000042915344},{"id":"https://openalex.org/keywords/topoisomerase-i-inhibitor","display_name":"topoisomerase I inhibitor","score":0.8809999823570251},{"id":"https://openalex.org/keywords/p21","display_name":"p21","score":0.718999981880188},{"id":"https://openalex.org/keywords/dr5","display_name":"DR5","score":0.8029999732971191},{"id":"https://openalex.org/keywords/dr4","display_name":"DR4","score":0.9049999713897705},{"id":"https://openalex.org/keywords/decoy-receptor","display_name":"decoy receptor","score":0.8149999976158142},{"id":"https://openalex.org/keywords/death-receptors","display_name":"death receptors","score":0.746999979019165},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.6570000052452087},{"id":"https://openalex.org/keywords/g2-m-cell-cycle-arrest","display_name":"G2/M cell cycle arrest","score":0.800000011920929},{"id":"https://openalex.org/keywords/caspase-3","display_name":"caspase-3","score":0.9330000281333923},{"id":"https://openalex.org/keywords/colon-cancer","display_name":"colon cancer","score":0.6890000104904175},{"id":"https://openalex.org/keywords/hct116-cells","display_name":"HCT116 cells","score":0.890999972820282},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.5249999761581421},{"id":"https://openalex.org/keywords/tumor-xenografts","display_name":"tumor xenografts","score":0.7889999747276306}],"concepts":[{"id":"https://openalex.org/C127561419","wikidata":"https://www.wikidata.org/wiki/Q224527","display_name":"Downregulation and upregulation","level":3,"score":0.7630755305290222},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.7331972718238831},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5956227779388428},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.5952949523925781},{"id":"https://openalex.org/C48297814","wikidata":"https://www.wikidata.org/wiki/Q14911965","display_name":"Caspase 8","level":5,"score":0.48957428336143494},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4653298258781433},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.4274928867816925},{"id":"https://openalex.org/C31573885","wikidata":"https://www.wikidata.org/wiki/Q304484","display_name":"Programmed cell death","level":3,"score":0.40106362104415894},{"id":"https://openalex.org/C12519072","wikidata":"https://www.wikidata.org/wiki/Q14914370","display_name":"Caspase 3","level":4,"score":0.38354480266571045},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.3754394054412842},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.12520954012870789},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000077146","descriptor_name":"Irinotecan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000972","descriptor_name":"Antineoplastic Agents, Phytogenic","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002277","descriptor_name":"Carcinoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D002277","descriptor_name":"Carcinoma","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D002277","descriptor_name":"Carcinoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D002453","descriptor_name":"Cell Cycle","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002478","descriptor_name":"Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003110","descriptor_name":"Colonic Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D003110","descriptor_name":"Colonic Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D003110","descriptor_name":"Colonic Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007700","descriptor_name":"Kinetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008562","descriptor_name":"Membrane Glycoproteins","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D012334","descriptor_name":"RNA, Neoplasm","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014409","descriptor_name":"Tumor Necrosis Factor-alpha","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D016213","descriptor_name":"Cyclins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018124","descriptor_name":"Receptors, Tumor Necrosis Factor","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D020169","descriptor_name":"Caspases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D050759","descriptor_name":"Cyclin-Dependent Kinase Inhibitor p21","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051017","descriptor_name":"Apoptosis Regulatory Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053221","descriptor_name":"TNF-Related Apoptosis-Inducing Ligand","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1038/sj.onc.1205449","doi":"https://doi.org/10.1038/sj.onc.1205449","is_oa":false,"landing_page_url":"https://doi.org/10.1038/sj.onc.1205449","pdf_url":null,"source":{"id":"https://openalex.org/S128439998","display_name":"Oncogene","issn_l":"0950-9232","issn":["0950-9232","1476-5594"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncogene","raw_type":"journal-article"},{"id":"pmid:12032863","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12032863","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncogene","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320332193","display_name":"Genentech","ror":"https://ror.org/04gndp242"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":39,"referenced_works":["https://openalex.org/W1484817497","https://openalex.org/W1974079602","https://openalex.org/W1976669434","https://openalex.org/W1978480779","https://openalex.org/W1982661150","https://openalex.org/W1984753317","https://openalex.org/W1988756673","https://openalex.org/W1990252673","https://openalex.org/W1992360356","https://openalex.org/W2012191027","https://openalex.org/W2015519364","https://openalex.org/W2019465386","https://openalex.org/W2044840009","https://openalex.org/W2049312704","https://openalex.org/W2052644553","https://openalex.org/W2055905844","https://openalex.org/W2056217426","https://openalex.org/W2057320402","https://openalex.org/W2058561774","https://openalex.org/W2070061120","https://openalex.org/W2070197281","https://openalex.org/W2084733813","https://openalex.org/W2085366240","https://openalex.org/W2087332988","https://openalex.org/W2089218510","https://openalex.org/W2098439946","https://openalex.org/W2106284224","https://openalex.org/W2119317267","https://openalex.org/W2126959399","https://openalex.org/W2130988210","https://openalex.org/W2141528632","https://openalex.org/W2156870300","https://openalex.org/W2158464454","https://openalex.org/W2171483351","https://openalex.org/W2246769930","https://openalex.org/W2319186687","https://openalex.org/W2329356826","https://openalex.org/W2330448769","https://openalex.org/W2428574125"],"related_works":["https://openalex.org/W1976905576","https://openalex.org/W2154563532","https://openalex.org/W2351574517","https://openalex.org/W2158895937","https://openalex.org/W7096332250","https://openalex.org/W2082368690","https://openalex.org/W2128380044","https://openalex.org/W2090443758","https://openalex.org/W1519516598","https://openalex.org/W2347242113"],"abstract_inverted_index":null,"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}